Recherchemedicale.com
Maladies de l'appareil digestif
Maladie des voies biliaires
Maladies des canaux biliaires
Cholestase
Cholestase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Cholestase
Biopsie hépatique
Bilirubine
Tests sanguins
Échographie
Voies biliaires
Biopsie hépatique
Cholestase
Symptômes
5
Démangeaisons
Sels biliaires
Douleurs abdominales
Cholestase
Malnutrition
Malabsorption
Prévention
5
Prévention
Maladies hépatiques
Alimentation
Santé hépatique
Contrôle du poids
Maladies hépatiques
Traitements
5
Acide ursodéoxycholique
Médicaments
Chirurgie
Obstruction des voies biliaires
Régime alimentaire
Cholestase
Suppléments
Vitamines liposolubles
Complications
5
Cirrhose
Insuffisance hépatique
Infections
Voies biliaires
Insuffisance hépatique
Cholestase
Facteurs de risque
5
Obésité
Maladies hépatiques
Cholestase gravidique
Femmes
Maladies auto-immunes
Cholangite sclérosante
Tabagisme
Maladies hépatiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cholestase : Questions médicales les plus fréquentes",
"headline": "Cholestase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cholestase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-27",
"dateModified": "2024-12-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cholestase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies des canaux biliaires",
"url": "https://recherchemedicale.com/mesh/D001649",
"about": {
"@type": "MedicalCondition",
"name": "Maladies des canaux biliaires",
"code": {
"@type": "MedicalCode",
"code": "D001649",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.130.120"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cholestase extrahépatique",
"alternateName": "Cholestasis, Extrahepatic",
"url": "https://recherchemedicale.com/mesh/D001651",
"about": {
"@type": "MedicalCondition",
"name": "Cholestase extrahépatique",
"code": {
"@type": "MedicalCode",
"code": "D001651",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.130.120.135.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Mirizzi",
"alternateName": "Mirizzi Syndrome",
"url": "https://recherchemedicale.com/mesh/D057792",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Mirizzi",
"code": {
"@type": "MedicalCode",
"code": "D057792",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.130.120.135.812"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cholestase",
"alternateName": "Cholestasis",
"code": {
"@type": "MedicalCode",
"code": "D002779",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Eva Gijbels",
"url": "https://recherchemedicale.com/author/Eva%20Gijbels",
"affiliation": {
"@type": "Organization",
"name": "Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium."
}
},
{
"@type": "Person",
"name": "Mathieu Vinken",
"url": "https://recherchemedicale.com/author/Mathieu%20Vinken",
"affiliation": {
"@type": "Organization",
"name": "Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium."
}
},
{
"@type": "Person",
"name": "Pieter Annaert",
"url": "https://recherchemedicale.com/author/Pieter%20Annaert",
"affiliation": {
"@type": "Organization",
"name": "Drug Delivery & Disposition, Department of Pharmaceutical & Pharmacological Sciences, Katholieke Universiteit Leuven, ON II Herestraat 49, Box 921, Leuven, 3000, Belgium."
}
},
{
"@type": "Person",
"name": "Verena Keitel",
"url": "https://recherchemedicale.com/author/Verena%20Keitel",
"affiliation": {
"@type": "Organization",
"name": "Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty at Heinrich-Heine-University, Düsseldorf, Germany. Verena.Keitel@med.uni-duesseldorf.de."
}
},
{
"@type": "Person",
"name": "Alanah Pieters",
"url": "https://recherchemedicale.com/author/Alanah%20Pieters",
"affiliation": {
"@type": "Organization",
"name": "Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neonatal Hyperbilirubinemia.",
"datePublished": "2022-06-01",
"url": "https://recherchemedicale.com/article/35667102",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/19382359-20220407-02"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperbilirubinemia and Hyponatremia as Predictors of Complicated Appendicitis.",
"datePublished": "2022-07-04",
"url": "https://recherchemedicale.com/article/35893118",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medsci10030036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperbilirubinemia and Choledocholithiasis in an Extremely Premature Neonate.",
"datePublished": "2023-08-01",
"url": "https://recherchemedicale.com/article/37561830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/19382359-20230613-04"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperbilirubinemia in hospitalized patients: Etiology and outcomes.",
"datePublished": "2023-06-30",
"url": "https://recherchemedicale.com/article/37386866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10815589231180498"
}
},
{
"@type": "ScholarlyArticle",
"name": "Results of the Study of the Auditory Analyzer in Newborns with Hyperbilirubinemia.",
"datePublished": "2023-12-04",
"url": "https://recherchemedicale.com/article/38050891",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5935/0946-5448.20230015"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://recherchemedicale.com/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladie des voies biliaires",
"item": "https://recherchemedicale.com/mesh/D001660"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies des canaux biliaires",
"item": "https://recherchemedicale.com/mesh/D001649"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cholestase",
"item": "https://recherchemedicale.com/mesh/D002779"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cholestase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cholestase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-02-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cholestase",
"description": "Comment diagnostiquer la cholestase ?\nQuels tests sanguins sont utilisés ?\nL'échographie est-elle utile ?\nQuand faire une biopsie hépatique ?\nQuels signes cliniques indiquent une cholestase ?",
"url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Hyperbilirubinemia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cholestase",
"description": "Quels sont les symptômes de la cholestase ?\nLa cholestase cause-t-elle des démangeaisons ?\nPeut-on avoir des douleurs abdominales ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des signes de malnutrition ?",
"url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Hyperbilirubinemia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cholestase",
"description": "Comment prévenir la cholestase ?\nL'alimentation joue-t-elle un rôle ?\nFaut-il éviter certains médicaments ?\nLes examens réguliers sont-ils importants ?\nLe contrôle du poids est-il essentiel ?",
"url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Hyperbilirubinemia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cholestase",
"description": "Quels traitements existent pour la cholestase ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nUn régime alimentaire peut-il aider ?\nDes suppléments sont-ils recommandés ?",
"url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Hyperbilirubinemia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cholestase",
"description": "Quelles complications peuvent survenir ?\nLa cholestase peut-elle causer des infections ?\nY a-t-il un risque de cirrhose ?\nL'insuffisance hépatique est-elle possible ?\nDes problèmes de coagulation peuvent-ils survenir ?",
"url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Hyperbilirubinemia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cholestase",
"description": "Quels sont les facteurs de risque de cholestase ?\nL'âge influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nLes maladies auto-immunes sont-elles un facteur ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Hyperbilirubinemia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la cholestase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, échographies et biopsies hépatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les niveaux de bilirubine, ALAT, ASAT et phosphatases alcalines."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie permet de visualiser les voies biliaires et détecter des obstructions."
}
},
{
"@type": "Question",
"name": "Quand faire une biopsie hépatique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie est envisagée si la cause de la cholestase n'est pas claire après d'autres tests."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une cholestase ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent jaunisse, prurit, et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la cholestase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent jaunisse, démangeaisons, fatigue et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "La cholestase cause-t-elle des démangeaisons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'accumulation de sels biliaires dans le sang provoque des démangeaisons."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs abdominales ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs dans la partie supérieure droite de l'abdomen peuvent survenir."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente en raison de l'accumulation de toxines dans le sang."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de malnutrition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une malabsorption des graisses peut entraîner des carences nutritionnelles."
}
},
{
"@type": "Question",
"name": "Comment prévenir la cholestase ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prévenir les maladies hépatiques et maintenir un mode de vie sain aide à réduire le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée et riche en fibres peut soutenir la santé hépatique."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aggraver la cholestase, consultez un médecin."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers du foie peuvent aider à détecter des problèmes précocement."
}
},
{
"@type": "Question",
"name": "Le contrôle du poids est-il essentiel ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé réduit le risque de maladies hépatiques et de cholestase."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la cholestase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des changements alimentaires et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme l'acide ursodéoxycholique peuvent améliorer l'écoulement biliaire."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée en cas d'obstruction des voies biliaires ou de lésions hépatiques."
}
},
{
"@type": "Question",
"name": "Un régime alimentaire peut-il aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime pauvre en graisses peut réduire les symptômes et améliorer la digestion."
}
},
{
"@type": "Question",
"name": "Des suppléments sont-ils recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de vitamines liposolubles peuvent être nécessaires en cas de malabsorption."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose, l'insuffisance hépatique et des infections."
}
},
{
"@type": "Question",
"name": "La cholestase peut-elle causer des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'accumulation de bile peut favoriser des infections des voies biliaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cirrhose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une cholestase prolongée peut entraîner une cirrhose et des dommages hépatiques irréversibles."
}
},
{
"@type": "Question",
"name": "L'insuffisance hépatique est-elle possible ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une cholestase sévère peut conduire à une insuffisance hépatique aiguë ou chronique."
}
},
{
"@type": "Question",
"name": "Des problèmes de coagulation peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la cholestase peut affecter la production de facteurs de coagulation, augmentant le risque de saignement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de cholestase ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, l'alcoolisme, et certaines maladies hépatiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cholestase augmente avec l'âge, surtout chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de cholestase, comme la cholestase gravidique, touchent plus les femmes."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la cholangite sclérosante peuvent augmenter le risque de cholestase."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les maladies hépatiques et augmenter le risque de cholestase."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/12/2024
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.
Publications dans "Cholestase" :
4 publications dans cette catégorie
Affiliations :
Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.
Publications dans "Cholestase" :
3 publications dans cette catégorie
Affiliations :
Drug Delivery & Disposition, Department of Pharmaceutical & Pharmacological Sciences, Katholieke Universiteit Leuven, ON II Herestraat 49, Box 921, Leuven, 3000, Belgium.
Publications dans "Cholestase" :
3 publications dans cette catégorie
Affiliations :
Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty at Heinrich-Heine-University, Düsseldorf, Germany. Verena.Keitel@med.uni-duesseldorf.de.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, School of Veterinary Medicine & Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva 87, Cidade Universitária, SP, 05508-270, Brazil.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Basic & Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Faculty of Medicine & Health Sciences, Ghent University, C Heymanslaan 10, Ghent, 9000, Belgium.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
European Reference Network on Hepatological Diseases (ERN RARE-LIVER), 20246 Hamburg, Germany.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai 201102, China.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai 201102, China.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Amsterdam University Medical Centers, Tytgat Institute for Liver and Intestinal Research, Research Institute Amsterdam Gastroenterology, Endocrinology and Metabolism (AGEM), University of Amsterdam, Amsterdam, Netherlands.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Digestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Digestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Division of Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, United States. james.squires2@chp.edu.
Publications dans "Cholestase" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands. u.h.beuers@amsterdamumc.nl.
Publications dans "Cholestase" :
Neonatal hyperbilirubinemia (NH) is a common phenomenon. In most cases, NH is benign and transient. However, in severe NH cases, neonates can develop encephalopathy and kernicterus. With appropriate s...
Several studies have reported elevated serum bilirubin or reduced serum sodium levels in patients with complicated appendicitis (CA). This study examined the efficacy of hyperbilirubinemia, hyponatrem...
Cholestasis affects 2% of newborns admitted to the neonatal intensive care unit and 20% of premature infants and requires a thoughtful evaluation and diagnostic workup.There may be a single responsibl...
There is little information on the differential diagnosis and prognosis of hospitalized patients with hyperbilirubinemia. Here, we hypothesized that hyperbilirubinemia in hospitalized patients is asso...
According to statistics, hyperbilirubinemia is observed during the first week of life in approximately 60% of full-term and 80% of premature newborns. It is known that indirect bilirubin has a neuroto...
Hyperbilirubinemia, presenting as jaundice, is a life-threatening critical illness in newborn babies and acute severe hepatic failure patients. Over the past few decades, extracorporeal hemoadsorption...
Neonatal hyperbilirubinemia (NHb) results from increased total serum bilirubin and is a common reason for admission and readmission amongst newborn infants born in North America. The use of intravenou...
Using national and provincial databases, a population-based retrospective cohort study of infants born in Ontario from April 2014 to March 2018 was conducted....
Of the 533,084 infants born in Ontario at ≥35 weeks gestation, 29,756 (5.6%) presented with NHb. Among these infants, 80.1-88.2% received phototherapy, 1.1-2.0% received IVIG therapy and 0.1-0.2% rece...
IVIG therapy is increasingly being used in Ontario despite limited studies evaluating its use. The results of this study could inform treatment and management protocols for NHb....
Clinically significant neonatal hyperbilirubinemia still occurs in Ontario, with an increasing number of infants receiving Intravenous Immunoglobulin G (IVIG) therapy. IVIG continues to be used at inc...
A review of the literature demonstrates that severe total hyperbilirubinemia (total serum bilirubin ≥ 20 mg/dL [340 µmol/L]) in some cholestatic term (≥37 weeks) and late-preterm (≥34...
It has been reported that preterm infants can develop feeding intolerance during phototherapy (PT) and that PT can affect mesenteric perfusion in these patients....
Our aim was to assess if PT can decrease regional splanchnic oxygenation (rSO...
We prospectively studied infants with gestational age of 25-34 weeks with hyperbilirubinemia requiring PT. Splanchnic regional oxygenation (rSO...
During PT rSO...
PT treatment decreases splanchnic oxygenation in preterm infants likely due to peripheral vasodilation which triggers a redistribution of blood flow. These results can help explain the association bet...
We aimed to evaluate the effect of hyperbilirubinemia and phototherapy on total apoptotic, platelet-derived, endothelial-derived, and tissue factor (TF)-positive apoptotic microparticle (MP) levels in...
Thirty-three term neonates with nonhemolytic pathologic hyperbilirubinemia and 25 healthy term neonates were included. MP levels were analyzed by flow cytometry using peripheral blood samples only onc...
The rates of total apoptotic and endothelial-derived apoptotic MPs were significantly higher in the study group than the control group before phototherapy (P = 0.012 and P = 0.003, respectively) and a...
Our study demonstrated that total apoptotic and endothelial-derived apoptotic MPs are increased in cases of nonhemolytic pathologic hyperbilirubinemia. We showed that phototherapy does not have a sign...